|
|
 |
|
 |
| |
|
USANZ Speakers
| Dr Bernard Bochner |
|
Professor Margit Fisch |
| |
|
 |
|
Awaiting further information
|
|
Prof. Margit Fisch is Fellow of the European Board of Urology (F.E.B.U.) and Fellow of the European Academy of Paediatric Urology (F.E.A.E.U.).
She trained with Prof. Rudolf Hohenfellner in Mainz, Germany, and became a staff member of the Dep. of Urology at Mainz Medical School in 1992. Her major scientific interest was and is reconstructive Urology, especially urinary diversion. In cooperation with the Center of Urology and Nephrology in Mansoura, Egypt, she did major contributions on ureteral implantation techniques and forms of urinary diversion using the anal sphincter. She developed and published the technique of the “Sigma-rectum Pouch”. In cooperation with the University College in Dublin, Ireland, techniques like the “transverse colonic pouch” have been created. From June 1997 to December 1999 Margit Fisch was Vice Chair of the Dep. of Urology at Mainz Medical School. After Prof. Hohenfellner retired in 1998 she worked with the new Chair, Prof. Thüroff. In 2000 she moved to Hamburg taking over the position as head of the Section Pediatric Urology at the AK Harburg and became Director of the Dep. of Urology and Pediatric Urology 2 years later.
Margit Fisch was president of the Society of Genito- Urinary Surgeons (GURS) and the European Society of Genito-Urinary Surgeons (ESGURS). Another field of her clinical interest is pediatric urology. She is member of the European Association of Pediatric Urology (ESPU), the American Academy of pediatrics (AAP) and the Society of Pediatric Urologic Surgeons (SPUS, 25 active members worldwide). She published more then 270 papers and book chapters, more then 90 as first author. She organizes every three years the International Meeting on Reconstructive Urology (IMORU), a live surgery meeting.
Since 2008 she is the first female Chair of a Urology Department (University Medical Center Hamburg-Eppendorf) in Germany.
|
|
Dr James Lingeman
|
|
Dr Chris McMahon
|
|

|
|

|
|
Dr. Lingeman is well known nationally and internationally for his interest in the area of kidney stone disease and minimally invasive urologic techniques.
He is currently Director of the International Kidney Stone Institute. He is Chairman of the Board of the Methodist Research Institute, Chairman of the Institutional Review Board at Methodist Hospital, and is currently a member of the Board of Directors of Clarian Health Partners, a healthcare system comprised of 17 hospitals in the State of Indiana. He is a past president of the Indiana State Urologic Society and past president of the North Central Section of the American Urological Association. He is a member of the American Association of Genitourinary Surgeons (AAGUS).
Dr. Lingeman is the author of approximately 300 scientific publications.
|
|
Chris G McMahon is a Consultant Sexual Health Physician and Fellow of the Royal Australian College of Physician’s Chapter of Sexual Medicine. He is an Associate Professor in the Faculty of Health Sciences, University of Sydney and the Director of the Australian Centre for Sexual Health in Sydney, Australia. Dr McMahon is a committee chairman for the WHO Second and Third International Consultation on Erectile and Sexual Dysfunction and a chairman of the International Society of Sexual Medicine (ISSM) medical and research standards committee. He is an Associate Editor of the Journal of Sexual Medicine, and a member of the editorial board of the International Journal of Sexual Health, Current Sexual Health Reports and an associate section editor of the British Journal of Urology. He is a referee for multiple international peer-reviewed medical journals including the Journal of Sexual Medicine, the Journal of Urology, Urology, European Journal of Urology, the British Journal of Urology, the International Journal of Impotence Research, the Medical Journal of Australia and Expert Opinion on Investigational Drugs. He is a member of several local, regional and international medical associations and a committee member of the International Society of Sexual Medicine (ISSM). He has been invited to lecture on sexual medicine worldwide and has published extensively on sexual health. He has published over 70 original research and invited review articles in peer reviewed international medical journals, and 16 book chapters. His recent research has focused on drug treatment for patients with refractory erectile dysfunction (ED) and drug treatment of premature ejaculation. He has been a Federal and State ministerial adviser, an adviser, expert witness and reviewer to several regulatory and statuary bodies on the provision and delivery of health care to men with sexual dysfunction and an adviser to several multi-national pharmaceutical and medical device companies.
|
| Professor Tony Mundy |
|
Dr Michael O'Donnell |
 |
|
 |
|
Tony Mundy is a Professor of Urology and Director of the Institute of Urology at University College London.
He was trained in surgery and urology at Guy’s Hospital in London where he became a Consultant in 1980. He worked part-time at Guy’s and part-time at St Peter’s Hospitals until they became part of UCLH. Tony then moved to full time at UCLH in 2000, to become Director of the Institute of Urology.
Tony is currently Medical Director responsible for Quality and Safety, Education and Training, and Research and Development; past President of the British Association of Urological Surgeons; a Member of Council and of the Executive of the Royal College of Surgeons of England. He is the civilian Consultant Urological Surgeon for the Royal Navy. He is an Honorary Professor of Medicine in the University of Crete and visiting Consultant Urological Surgeon to the Republic of Malta.
Tony has had 37 visiting professorships, 280 invited lectures and been 91 times visiting surgeon to various institutions around the world. He has given 489 presentations to learned societies, published 182 original papers in peer review journals, 57 chapters and 12 books. He is an honorary member of various urological societies around the world and am particularly pleased to be an Honorary Member of the Urological Society of Australasia since 1982. He is a member of various editorial boards of urological journals and an external assessor of various universities and trustee of various urological research bodies and am foundation member of the Society of Genito-Urinary Reconstructive Surgeons and of the European and British Societies of Genito-Urinary Reconstructive Surgery.
|
|
Michael A. O’Donnell, MD, FACS, is Professor and Director of Urologic Oncology at the University of Iowa Carver College of Medicine. He received his medical degree from Duke University and completed his urological training at Brigham and Women’s Hospital in Boston, Massachusetts.
After completing a urologic oncology fellowship at Beth Israel Hospital and the Whitehead Institute in Boston, he joined Harvard Medical School faculty as Assistant Professor of Urology.
Dr. O’Donnell is the author of over 80 peer-reviewed manuscripts, 13 book chapters, and multiple reviews and abstracts. He has lead several national bladder cancer clinical trials using immune therapy and holds patents in the genetic manipulation of BCG bacteria.
|
|
Mr Julian Shah
|
|
|
| |
|
|
| Awaiting further information |
|
|
|
ANZUNS Speakers
|
|
Mary Chiarella
|
|
Helen Crowe
|
|

|
|

|
|
Mary’s career spans 40 years both in the United Kingdom and Australia across a variety of nursing services.
Mary is Professor of Nursing at the University of Sydney. In 2003/04 she was the Chief Nursing Officer, NSW Health Department and prior to that was the Foundation Professor of Nursing in Corrections Health, with the University of Technology, Sydney.
Mary has provided her professional expertise to health services, organisations and governments over the years. Examples include a review of professional practice and boundary issues for Justice Health, membership of the NSW Law Reform Commission Division Working Group on minor’s consent to medical treatment. She was a founding member of the Australian Bioethics Association and the Australian Institute for Health, Law and Ethics, was Chair of the Australian Nursing and Midwifery Council from 2007 -2009 and is currently a member of the Clinical Ethics Advisory Panel for NSW Health; the NSW nominee on the Nurses and Midwives Board of Australia (NMBA); Chair of the Policy Working Group of NMBA and has just been appointed as one of the Federal Minister for Health’s three independent members on the Board of Health Workforce Australia..
Mary’s particular research interests focus on legal, policy and ethical issues in nursing and health care delivery. She publishes and speaks nationally and internationally on her work. Examples of her research include an international review of nursing regulation; an examination of the legal and professional status of nurses; reviews and analyses of disciplinary decisions of professional Tribunals; and an international review of policy in end-of-life care. Recent research includes a state-wide review of advanced practice roles for the Nursing and Midwifery Office of the NSW Health Department; a second review of the disciplinary decisions of the NSW Nurses and Midwives Board; a review of the implementation of nurse practitioners in South Australia and an evaluation of the continuing competence framework for the New Zealand Nursing Council. She has undertaken a number of projects for the WHO, including a global review of nurse-led models of primary health care; a review of policy and leadership in primary health care and policy development related to MDG 5. She continues to work closely with the Nursing and Midwifery Office of NSW Health and is currently leading two state-wide projects: a second review of nursing care models in haemodialysis and a new project on the perioperative nursing workforce.
|
|
Helen has been working in urology for over 18 years, and was instrumental in establishing urology nursing professional organisations in Australia.
She is employed in a private practice as a Nurse Practitioner and at the Australian Centre for Prostate Cancer Research @ Epworth as a research nurse. Helen has extensive urological clinical and research experience and has over 20 publications in peer-reviewed journals.
Her clinical work now is primarily in the care of patients with prostate cancer.
|
|
Jenny Roberts
|
|
|
 |
|
 |
|
Jenny Roberts completed her registered nurse training at Christchurch Hospital in the late 1970's and worked in both medical and surgical areas before becoming a Charge Nurse at Southern Cross Hospital.
Since completing her Stomal Therapy training in 2000 she has been employed by Nurse Maude, a community based acute nursing and homecare organisation in Canterbury.
In her role as a Stomal Therapist, Jenny enjoys being part of a multi disciplinary team working with all age groups, in both hospital and home settings.
In 2005 Jenny was a recipient of the Campbell Ballantyne Fellowship grant. This enabled her to travel to Hong Kong to attend a world Stomal Therapy conference and then go on to England where she spent time at St Mark's Hospital in London, and the Hope Hospital in Manchester, studying all aspects of stoma management.
|
|
Kay Talbot (RN BAppSc, Dip Mgt. Prostate Care Nurse), has been involved in Urological nursing for many years. In that time she has developed particular interests in the areas of continence management, erectile dysfunction, nursing education, and the nursing management of patients having urological reconstructive and prosthetic surgery. She has extensive experience in each of these areas, and enjoys guiding the patient through their urological care pathway.
She was a founding member of the Victorian Urological Nurses Society, and the inaugural president and meeting convenor of the Australia and New Zealand Urological Nurses Society
|
|
|
|
 |
|
 |
|
|